INSIGHTS ON CLINICAL TRIAL DESIGN

• The Latest Generation Of Patient Recruitment Has Arrived

  In the final session of our three-part webinar series, we explore what this next phase of evolution means for clinical trial planning and execution, and examine how innovative approaches are reshaping recruitment strategies from the ground up.

• The Growing Complexity Of Conducting Oncology Trials

  As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.

• Control And Transparency: Solving Sponsors' Key Challenges In Study Launch

  Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.

• How To Accelerate Early-Phase Oncology Trial

  Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.

• FDA Draft Guidance On Diversity Action Plan Requirements

  10/24/2024

  Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.

• Smarter, More Accurate Patient Matching Enhances Trial Efficiency

  5/20/2025

  Even when patient recruitment criteria grows complex, this direct-to-data approach can pinpoint precise patients needed and provide an alert to your team when they are found.

• Delivering A Registrational GI Trial Through Ongoing Protocol Shifts

  10/17/2025

  A biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.

• Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies

  8/29/2025

  Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.

• Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions

  5/8/2026

  Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.